Startup India Government of India
Clarshen Pharmaceuticals Private Limited
Clarshen Pharmaceuticals Private Limited - chemicals in Patna, Bihar, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹26.96 Lakh
▲ 845% YoY
Net profit · FY 2025
₹87,544
Net margin 3.2%
EBITDA · FY 2025
₹87,544
EBITDA margin 3.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Clarshen Pharmaceuticals Private Limited
Data last updated:
Clarshen Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 16 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24230BR2019PTC041758. Its GSTIN is 10AAICC1315R1ZS (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhavana and Subhash Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat Number 104 Rajeshwar Apartment Gola Road Sainik Colony, Patna, Bihar, India – 801503.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.96 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹87,544 (net margin 3.2%) and EBITDA of ₹87,544 (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 126% over three years.
Clarshen Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0011248).
Company details
CIN U24230BR2019PTC041758
Registration Number 041758
Incorporation Date 16 April 2019
ROC Patna
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0011248
Key People
Bhavana Director Subhash Kumar Director Recognitions & Rankings of Clarshen Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0011248
Contact details
Clarshen Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressFlat Number 104 Rajeshwar Apartment Gola Road Sainik Colony, Patna, Bihar, India – 801503
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Clarshen Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Clarshen Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Clarshen Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Clarshen Pharmaceuticals Private Limited, buy the company report.
Financials of Clarshen Pharmaceuticals Private Limited
FY 2025 filings availableClarshen Pharmaceuticals Private Limited reported revenue of ₹26.96 Lakh (up 845% YoY) for FY 2025.
Revenue · FY 2025
₹26.96 Lakh ▲ 845%
Net profit · FY 2025
₹87,544 margin 3.2%
EBITDA · FY 2025
₹87,544 margin 3.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 845%
3 years · compounded
▲ 126%
EBITDA CAGR growth
1 year
▲ 168%
3 years · compounded
▲ 46%
5 years · compounded
▲ 21%
Revenue has grown at a compounded annual rate (CAGR) of 126% over three years, including 845% growth in the latest year. EBITDA rose 168% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹87,544 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹87,544 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Clarshen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Clarshen Pharmaceuticals Private Limited
Clarshen Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhavana Also directs: Bhumihar Mahila Samaj Foundation | Director | 07 Mar 2024 | 2 Years 8 Months | Current |
| Subhash Kumar | Director | 10 May 2024 | 2 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Clarshen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Clarshen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Clarshen Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAICC1315R1ZS | Bihar | Active | 02 Jun 2022 |
To see the full GST registrations and return filing status of Clarshen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Clarshen Pharmaceuticals Private Limited has 6 board changes on record since 2021: 2 appointments and 4 cessations. The latest: Arvind Kumar ceased to be Director on 18 May 2024.
AGM
Clarshen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Clarshen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna.
Ceased
Arvind Kumar ceased to be Director.
Ceased
Rina Devi ceased to be Director.
Appointed
Subhash Kumar was appointed as Director.
Appointed
Bhavana was appointed as Director.
Ceased
Subhash Kumar ceased to be Director.
Ceased
Rajeev Nayan Verma ceased to be Director.
Incorporation
16 Apr 2019
Clarshen Pharmaceuticals Private Limited was registered on 16 Apr 2019 with Roc Patna & aged 7 years 7 months as per MCA records.
Frequently asked questions
Clarshen Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 16 April 2019 (7+ years old) and is registered under CIN U24230BR2019PTC041758.
Clarshen Pharmaceuticals has 2 current directors:
- Bhavana - Director
- Subhash Kumar - Director
The latest financial statements of Clarshen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Clarshen Pharmaceuticals is 10AAICC1315R1ZS, registered in Bihar.
The CIN (Corporate Identification Number) of Clarshen Pharmaceuticals is U24230BR2019PTC041758. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clarshen Pharmaceuticals was incorporated on 16 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Patna.
Arvind Kumar ceased to be Director on 18 May 2024. Rina Devi ceased to be Director on 18 May 2024. Subhash Kumar was appointed as Director on 10 May 2024. Clarshen Pharmaceuticals has 6 board changes on record in total.
Yes, Clarshen Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Clarshen Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0011248).
The registered office of Clarshen Pharmaceuticals is at Flat Number 104 Rajeshwar Apartment Gola Road Sainik Colony, Patna, Bihar, India – 801503.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages